⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PTGX News
Protagonist Therapeutics, Inc
A Phase 3 Win and a 130% Takeover Premium Lit Up Rare Blood-Disease Stocks on Monday
prnewswire.com
AGIO
KROS
PTGX
IRON
SLN
Global Alzheimer’s Disease Biomarker Market Poised for Phenomenal Expansion at a Growth Rate of ~9% by 2034 | DelveInsight
globenewswire.com
ABT
BIO
AMGN
BMY
AXSM
JNJ
LLY
NVO
QTRX
DGX
TMO
QRVO
GILD
REGN
BIIB
ALKS
ACAD
PTGX
CRIS
EXAS
TDOC
QRHC
AMZN
GOOG
MSFT
IBM
NVDA
INTC
AMD
QCOM
AMAT
LRCX
KLAC
MU
ADI
NXPI
TXN
MRVL
ON
CDNS
SNPS
MCHP
AEHR
ENPH
PLUG
FCEL
PLTR
AI
CRBU
EDIT
BEAM
NTLA
BNTX
MRNA
PFE
JAZZ
ACGL
ZBRA
MSCI
ROST
SWKS
MDT
TNDM
XRAY
ALGN
IDXX
EXPE
CTAS
ILMN
DXCM
ASML
ADBE
Paytronix Introduces Messaging to Access Evo to Help Brands Measure and Act on What Brings Guests Back
globenewswire.com
PTGX
AmMax Bio Names Suneel K. Gupta, Ph.D. as Chief Scientific Officer to Advance Novel ADC Portfolio
globenewswire.com
PTGX
IMRX
Protagonist Therapeutics Announces $300 Million Share Repurchase Program
accessnewswire.com
PTGX
Chronic Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Domain | DelveInsight
globenewswire.com
TLRY
TAK
TNDM
NVS
BMY
PFE
INCY
JNJ
AZN
MRK
ABBV
CRSP
SCLX
RIGL
JAZZ
GILD
REGN
AMGN
BIIB
PTGX
EXAS
SNOW
SRPT
VRTX
BNTX
ALKS
RGEN
IMUX
ADPT
ATRC
CRNX
CYTK
DTIL
EXEL
FGEN
GALT
GNTX
GRFS
GSK
HRMY
IDXX
ILMN
INSM
IONS
IRWD
KODK
LAKE
LULU
LYFT
MAR
MDLZ
MELI
MIRM
MNKD
MRNA
MTCH
NBIX
NCLH
NEM
NTRA
NVCR
ODFL
OMER
ORGO
OTEX
PACB
PBYI
PCAR
PEGA
PERI
PETS
PLRX
PMVP
PPC
PRGS
PRTA
PSNL
PTN
PZZA
QGEN
QTRX
RARE
RCEL
RDHL
RLAY
RLGT
RMD
ROST
RRX
RYAAY
RYTM
SAN
SBAC
SBRA
SEIC
SIGA
SIRI
SITE
SLAB
SLGN
SMCI
SMMT
SNPS
SNY
SOFI
SONO
SPCE
SSYS
STNG
STRA
STRL
STX
SWKS
SYK
SYNA
TCOM
TDOC
TECK
TEVA
TFX
TGTX
TIGR
TRMB
TRVG
TTWO
TUSK
TXRH
ULTA
UMC
UNFI
UNH
URBN
UTHR
VEEV
VELO
VERU
VIVO
VKTX
VLRS
VNDA
VRSK
VSAT
VTGN
WDC
WEC
WERN
WGO
WIX
WMB
WST
WTW
WYNN
XOM
XPER
XPO
XRAY
YETI
YRD
YUM
ZBRA
ZLAB
ZYME
Protagonist Therapeutics to Participate in Two Investment Bank Conferences in September 2026
accessnewswire.com
PTGX
Protagonist Therapeutics Announces U.S. FDA Approval of Hepcidin Mimetic Peptide MIMRYLO(TM) (rusfertide) for Polycythemia Vera
accessnewswire.com
PTGX
Protagonist Therapeutics Reports Granting of Inducement Awards
accessnewswire.com
PTGX
Global Neurodegenerative Disease Market is Expected to Showcase Significant Growth at a CAGR of ~6% by 2034 | DelveInsight
globenewswire.com
NVO
LLY
BMY
AXSM
JNJ
SNY
BIIB
ABBV
MRK
REGN
GILD
AMGN
AZN
TEVA
BHC
ALKS
VRTX
SRPT
CRIS
NTLA
EDIT
INCY
ACAD
ALNY
CYTK
IONS
EXAS
IDXX
VNDA
SUPN
RGNX
XOM
CVAC
BNTX
ARCT
MRNA
NBIX
ADPT
AVXL
IMUX
PRGS
RDNT
CRDF
ADSK
ANAB
ATRC
CLDX
CPRX
ESPR
EXEL
FGEN
GALT
GRFS
HRMY
IGC
INSM
KODK
LAKE
LCTX
LEXX
LPCN
MESO
MITK
MNKD
MSFT
MYGN
NEO
NVCR
NXPI
OCGN
OMER
ORCL
PACB
PFE
PLRX
PRGO
PSNL
PTGX
QGEN
RARE
ROST
RVMD
SEIC
SIGA
SMCI
SNOW
SOFI
SPRO
TGTX
TNDM
TXG
ULTA
VEEV
VKTX
VRNS
WVE
XRAY
ZBRA
ZNTL